Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 16,231	$ 10,112	$ 41,340	$ 22,661
General and administrative	5,739	4,945	11,887	9,417
Total operating expenses	21,970	15,057	53,227	32,078
Loss from operations	(21,970)	(15,057)	(53,227)	(32,078)
Other income (expense):
Interest income	2,239	263	3,862	289
Interest expense	(914)	(128)	(1,789)	(246)
Other income	511	325	953	640
Change in fair value of non-marketable equity securities	(28)	(256)	(30)	(543)
Total other income	1,808	204	2,996	140
Net loss	(20,162)	(14,853)	(50,231)	(31,938)
Other comprehensive loss:
Change in unrealized loss on marketable securities	(138)	(140)	82	(152)
Comprehensive loss	$ (20,300)	$ (14,993)	$ (50,149)	$ (32,090)
Net loss per share attributable to common stockholders, basic	$ (0.46)	$ (0.55)	$ (1.23)	$ (1.24)
Net loss per share attributable to common stockholders, diluted	$ (0.46)	$ (0.55)	$ (1.23)	$ (1.24)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic	44,269,772	27,078,450	40,986,907	25,660,742
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted	44,269,772	27,078,450	40,986,907	25,660,742